Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma

Featuring perspectives from Dr Jesús G Berdeja and Dr Thomas Martin, including the following topics:

• Introduction: Real-World Regulatory Issues in Multiple Myeloma (MM) (0:00)
• Newly Diagnosed MM (14:30)
• Novel Agents for Relapsed/Refractory MM (24:58)
• Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies (44:28)

CME information and select publications